elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38935390-16933E82-ACE7-4EC7-8AE8-FF9753965A51
Q38935390-16933E82-ACE7-4EC7-8AE8-FF9753965A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38935390-16933E82-ACE7-4EC7-8AE8-FF9753965A51
Protein-protein interaction inhibitors: advances in anticancer drug design.
P2860
Q38935390-16933E82-ACE7-4EC7-8AE8-FF9753965A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38935390-16933E82-ACE7-4EC7-8AE8-FF9753965A51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30b7537099676495b08f951c75af753e35e78c20
P2860
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors